Triple
T22693621
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Teglutik |
E561110
|
entity |
| Predicate | primaryMetabolizingEnzyme |
P37221
|
FINISHED |
| Object | CYP1A2 |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CYP1A2 | Statement: [Teglutik, primaryMetabolizingEnzyme, CYP1A2]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CYP1A2 Context triple: [Teglutik, primaryMetabolizingEnzyme, CYP1A2]
-
A.
CYP1A2
chosen
CYP1A2 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs and xenobiotics.
-
B.
CYP2B6
CYP2B6 is a human liver cytochrome P450 enzyme that plays a key role in the metabolism of various drugs and xenobiotics.
-
C.
CYP2D6
CYP2D6 is a highly polymorphic cytochrome P450 enzyme that plays a major role in the metabolism of many drugs, contributing significantly to interindividual variability in drug response.
-
D.
CYP3A5
CYP3A5 is a liver-expressed cytochrome P450 enzyme that metabolizes various drugs and xenobiotics, contributing to interindividual variability in drug clearance.
-
E.
CYP2C9
CYP2C9 is a liver enzyme of the cytochrome P450 family that plays a key role in metabolizing various drugs, including many nonsteroidal anti-inflammatory agents and anticoagulants.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: primaryMetabolizingEnzyme Context triple: [Teglutik, primaryMetabolizingEnzyme, CYP1A2]
-
A.
isMetabolizedBy
chosen
Indicates that a substance is biochemically broken down or transformed through metabolic processes carried out by a specified organism, cell type, or enzyme system.
-
B.
isMetabolizedPrimarilyIn
Indicates that the substance undergoes its main metabolic processing within the specified biological system or organ.
-
C.
primaryMetabolite
Indicates that one entity is a primary metabolite, i.e., a small molecule directly involved in essential cellular metabolic processes.
-
D.
isMetabolizedExtent
Indicates the degree or proportion to which one substance is metabolized by another biological system or agent.
-
E.
hasActiveMetabolite
Indicates that a substance produces one or more metabolites that remain pharmacologically active in the body.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789c6ae481908975b7d27e7624ac |
completed | April 29, 2026, 3:18 a.m. |
| PD | Predicate disambiguation | batch_69ee62b2259c819091ed1387a748b9f3 |
completed | April 26, 2026, 7:08 p.m. |
Created at: April 17, 2026, 3:13 p.m.